Child height, health and human capital: evidence using genetic markers

Working Pape

Genetic markers as instrumental variables: an application to child fat mass and academic achievement

Working Pape

Is the Healthy Start scheme associated with increased food expenditure in low-income families with young children in the United Kingdom?

Introduction: Healthy Start is a food assistance programme in the United Kingdom (UK) which aims to provide a nutritional safety-net and enable low-income families on welfare benefits to access a healthier diet through the provision of food vouchers. Healthy Start was launched in 2006 but remains under-evaluated. This study aims to determine whether participation in the Healthy Start scheme is associated with differences in food expenditure in a nationally representative sample of households in the UK. Methods: Cross-sectional analyses of the Living Costs and Food Survey dataset (2010-2017). All households with a child (0-3 years) or pregnant woman were included in the analysis (n=4,869). Multivariable quantile regression compared the expenditure and quantity of fruit and vegetables (FV), infant formula and total food purchases. Four exposure groups were defined based on eligibility, participation and income (Healthy Start Participating, Eligible Non-participating, Nearly Eligible low-income and Ineligible high-income households). Results: Of 876 eligible households, 54% participated in Healthy Start. No significant differences were found in FV or total food purchases between participating and eligible non-participating households, but infant formula purchases were lower in Healthy Start participating households. Ineligible higher-income households had higher purchases of FV. Conclusion: This study did not find evidence of an association between Healthy Start participation and FV expenditure. Moreover, inequalities in FV purchasing persist in the UK. Higher participation and increased voucher value may be needed to improve programme performance and counteract the harmful effects of poverty on diet

LAS BATALLAS FESTIVAS DE ESPANA

Serving individual customer needs at reasonable prices can be a profitable target market in high-wage countries. The dilemma between scale and scope-oriented production is one major research topic within the Cluster of Excellence "Integrative Production Technology for High-Wage Countries" at the RWTH Aachen University. One main objective of this project is to bridge the existing gap between individual manufacturing and mass production. Modularization is a widely accepted approach in tool-based manufacturing processes. In this paper, we propose a flexible design methodology for modular tools and dies. The methodology will assist the design engineer in setting up a series of modularized tools in a conceptually closed manner. The described methodology covers modularization in a broad sense, i.e. it includes hardware modularization as well as modularization of the construction process. The methodology consists of three phases: initiation, analysis and design phase

Разработка электроэнцефалографа на наносенсорах для исследования мозга человека в расширенном диапазоне частот

В выпускной квалификационной работе проведен анализ методов исследования мозга человека. Выбрана электроэнцефалография в качестве основного метода регистрации биоэлектрической активности с помощью наносенсоров. Разработан электроэнцефалограф для исследования мозга человека в расширенном диапазоне частот (0-10000 Гц), позволяющий получить дополнительную информацию о регистрируемых биопотенциалах и ритмах ЭЭГ. Проведено исследование для оценки психоэмоционального состояния человека и исследование для подтверждения возможности использования разработанного электроэнцефалографа в качестве электронейромиографа.IIn the final qualifying work, an analysis of methods of studying the human brain was carried out. Electroencephalography was chosen as the main method for recording bioelectrical activity with nanosensors. The developer is an electroencephalograph for studying the human brain in the extended frequency range (0-10000 Hz), which allows obtaining additional information on the detected bioelectric potentials and EEG rhythms. A study was conducted to assess the psychoemotional state of a person and study to confirm the possibility of using the developed electroencephalograph as an electroneuromiograph

Intraperitoneal bevacizumab for control of malignant ascites due to advanced-stage gastrointestinal cancers: A multicentre double-blind, placebo-controlled phase II study - AIO SUP-0108

PURPOSE: Malignant ascites is debilitating for patients with advanced cancer. As shown previously, tumour cell production of vascular endothelial growth factor might be a major cause of the formation of malignant ascites. Intraperitoneal bevacizumab could therefore be an option for symptom control in refractory ascites. PATIENTS AND METHODS: Patients with advanced gastrointestinal cancer and malignant ascites who had undergone paracentesis at least twice within the past 4 weeks were randomly assigned in a 2:1 ratio to intraperitoneal bevacizumab (400 mg absolute) or placebo after paracentesis. During the 8-week treatment period, a minimum interval of 14 d was kept between the applications of the study drug. Primary end-point was paracentesis-free survival (ParFS). RESULTS: Fifty-three patients (median age 63 years) were randomised. Forty-nine patients received at least one study drug application and qualified for the main analysis. The proportion of patients with at least one common toxicity criteria grade III-V event was similar with 20/33 (61%) on bevacizumab and 11/16 (69%) on placebo. Median ParFS was 14 d (95% confidence interval [CI]: 11-17) in the bevacizumab arm and 10.5 d (95% CI: 7-21) on placebo (hazard ratio 0.74, 95% CI: 0.40-1.37; P = 0.16). The longest paracentesis-free period was 19 d on bevacizumab (range 6-66 d) and 17.5 d in the placebo arm (range 4-42) (P = 0.85). Median overall survival was 64 d (95% CI: 45-103) on bevacizumab compared to 31.5 d (95% CI: 20-117) on placebo (P = 0.31). CONCLUSION: Intraperitoneal bevacizumab was well tolerated. Overall, treatment did not result in a significantly better symptom control of malignant ascites. However, patients defined by specific immune characteristics may benefit

A genome-wide screen identifies genes that suppress the accumulation of spontaneous mutations in young and aged yeast cells

To ensure proper transmission of genetic information, cells need to preserve and faithfully replicate their genome, and failure to do so leads to genome instability, a hallmark of both cancer and aging. Defects in genes involved in guarding genome stability cause several human progeroid syndromes, and an age-dependent accumulation of mutations has been observed in different organisms, from yeast to mammals. However, it is unclear whether the spontaneous mutation rate changes during aging and whether specific pathways are important for genome maintenance in old cells. We developed a high-throughput replica-pinning approach to screen for genes important to suppress the accumulation of spontaneous mutations during yeast replicative aging. We found 13 known mutation suppression genes, and 31 genes that had no previous link to spontaneous mutagenesis, and all acted independently of age. Importantly, we identified PEX19, encoding an evolutionarily conserved peroxisome biogenesis factor, as an age-specific mutation suppression gene. While wild-type and pex19Δ young cells have similar spontaneous mutation rates, aged cells lacking PEX19 display an elevated mutation rate. This finding suggests that functional peroxisomes may be important to preserve genome integrity specifically in old cells